CHE (Chemed Corporation) Stock Analysis - Analyst Ratings

Chemed Corporation (CHE) is a publicly traded Healthcare sector company. As of May 21, 2026, CHE trades at $440.98 with a market cap of $5.86B and a P/E ratio of 23.99. CHE moved +0.10% today. Year to date, CHE is +0.83%; over the trailing twelve months it is -24.05%. Its 52-week range spans $365.21 to $623.61. Analyst consensus is neutral with an average price target of $446.50. Rallies surfaces CHE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate CHE?

4 analysts cover CHE: 0 strong buy, 1 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $446.50.

CHE Key Metrics

Key financial metrics for CHE
MetricValue
Price$440.98
Market Cap$5.86B
P/E Ratio23.99
EPS$18.36
Dividend Yield0.60%
52-Week High$623.61
52-Week Low$365.21
Volume2
Avg Volume0
Revenue (TTM)$2.54B
Net Income$259.78M
Gross Margin32.38%

CHE Analyst Consensus

4 analysts cover CHE: 0 strong buy, 1 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $446.50.

Latest CHE News

Recent CHE Insider Trades

  • GRACE PATRICK P sold 60 (~$25.55K) on May 8, 2026.
  • MCNAMARA KEVIN J sold 2.00K (~$842.26K) on May 1, 2026.
  • MCNAMARA KEVIN J sold 1.50K (~$554.05K) on Mar 27, 2026.

Common questions about CHE

What do analysts rate CHE?
4 analysts cover CHE: 0 strong buy, 1 buy, 3 hold, 0 sell, and 0 strong sell. The consensus rating is neutral. The average price target is $446.50.
Does Rallies show CHE price targets?
Yes. Rallies tracks CHE analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is CHE research on Rallies investment advice?
No. Rallies provides research, data, and educational context for CHE. It does not provide personalized investment advice.
CHE

CHE